3572
Helvetica Chimica Acta Vol. 85(2002)
4-[(tert-Butyl)dimethylsilyl]but-4-en-1-ol (34). Prepared according to GP 2 from 2-vinyloxirane (80.5 ml,
1.0 mmol), reagent 1 (402 mg, 1.5mmol), and AIBN (50 mg, 0.3 mmol) in pentane (4 ml); 6 h. FC (pentane/
Et2O 8 :2) afforded 34 (114 mg, 61%) as a colorless oil. Diastereoisomer ratio: (E)/(Z) 22 :10. IR (nujol):
3343m (br.), 2953s, 2929s, 2883m, 2858s, 1470m, 1404w, 1362w, 1252m, 1154w, 1005m, 967m, 827s, 804m, 749w.
1H-NMR (300 MHz, CDCl3): (E)-34: 5.75 5.46 (m, CHCH); 4.02 (d, J 6.3, CH2OH); 1.73 (s, OH); 1.51
(d, J 8.3, CH2Si); 0.88 (s, tBu); À0.05( s, Me2Si). 1H-NMR (300 MHz, CDCl3): (Z)-34: 5.75 5.46
(m, CHCH); 4.16 (d, J 6.6, CH2OH); 1.73 (s, OH); 1.55 1.50 (m, CH2Si); 0.88 (s, tBu); À0.05( s, Me2Si).
13C-NMR (75MHz, CDCl 3): (E)-34: 131.1 (CH); 127.5(CH); 64.2 (CH 2); 26.5(Me); 23.5(C q); 18.8 (CH2);
t
À6.5(Me). EI-MS: 132 (3), 129 (2, [ M À Bu] ), 76 (7), 75(100), 73 (32), 54 (5), 40 (8). HR-EI-MS: 129.0726
([M tBu] , C6H13OSi ; calc. 129.0736).
4-[Dimethyl(phenyl)silyl]but-2-en-1-ol (35). Prepared according to GP 2 from 2-ethenyloxirane (95 ml,
1.2 mmol), 6 (514 mg, 1.8 mmol), and AIBN (60 mg, 0.4 mmol) in hexane (4 ml); 5 h. FC (pentane/Et2O 8 :2)
afforded 35 (84 mg, 35%) as a colorless oil. Diastereoisomer ratio: (E)/(Z) 44 :10. The NMR-data for the (E)-
isomer are in agreement with those reported in [32]. 1H-NMR (200 MHz, CDCl3): (Z)-35: 7.54 7.46
(m, 2 arom. H); 7.37 7.33 (m, 3 arom. H); 5.75 5.42 (m, CHCH); 3.95( d, J 6.2, CH2OH); 1.78 1.71
(m, CH2Si); 0.31 (s, Me2Si). 13C-NMR (75MHz, CDCl 3): (Z)-35: 138.4 (Cq); 133.6 (CH); 129.2 (CH); 128.5
(CH); 127.8 (CH); 126.6 (CH); 58.3 (CH2); 18.4 (CH2); À3.4 (Me).
Dimethyl 3-Methyl-4-[(triisopropylsilyl)methyl]cyclopentane-1,1-dicarboxylate (39, representative exam-
ple, cf. Scheme 8): Prepared according to GP 2 from 36 (217 mg, 1.02 mmol), 5 (666 mg, 2.15mmol), and
(tBuO)2 (100 ml, 0.54 mmol) in hexane (4 ml); 6 h, 1408. FC (pentane/tBuOMe 40 :1) afforded 39 (311 mg,
0.84 mmol, 82%) as a colorless oil. Diastereoisomer ratio: cis/trans 26 :10. IR (nujol): 2944s, 2891m, 2866s,
1736s, 1362m, 1435m, 1254s, 1202m, 1153m, 882m. 1H-NMR (300 MHz, CDCl3): cis-39: 3.70 (s, MeO); 3.69
(s, MeO); 2.41 (dd, J1 13.1, J2 6.4, 1 H, CH2); 2.38 2.33 (m, 1 H, CH2); 2.20 2.00 (m, 3 H, CH2, CH); 1.91
(dd, J1 13.1, J2 10.4, 1 H, CH2); 1.11 0.98 (m, 3 Me2CH); 1.03 (br. s, 3 Me2CH); 0.85( d, J 6.9, MeCH);
0.69 (dd, J1 15.0, J2 3.5, 1 H, CH2Si); 0.49 (dd, J1 14.9, J2 10.3, 1 H, CH2Si). 1H-NMR (300 MHz, CDCl3):
trans-39: 3.70 (s, MeO); 3.69 (s, MeO); 2.62 (dd, J1 14.1, J2 8.2, 1 H, CH2); 2.50 (dd, J1 13.6, J2 6.9, 1 H,
CH2); 1.73 1.63 (m, 2 H, CH, CH2); 1.52 1.44 (m, 2 H, CH, CH2); 1.11 0.98 (m, Me2CH); 1.03 (br. s,
3 Me2CH); 0.85( d, J 6.9, MeCH); 0.76 (dd, J1 15.0, J2 3.4, 1 H, CH2Si); 0.36 (dd, J1 15.0, J2 11.3,
CH2Si). 13C-NMR (75MHz, CDCl 3): cis-39: 173.6 (Cq); 173.4 (Cq); 59.0 (Cq); 52.6 (Me); 41.0 (CH2); 40.6 (Me);
38.4 (2 CH); 18.8 (Me); 14.8 (Me); 11.4 (CH); 8.9 (CH2). 13C-NMR (75MHz, CDCl 3): trans-39: 173.6 (Cq);
173.4 (Cq); 58.2 (Cq); 52.6 (Me); 44.1 (CH); 43.2 (CH); 42.0 (2 CH2); 24.4 (Me); 18.2 (Me); 11.4 (CH); 9.3
i
(CH2). EI-MS: 329.1 (8), 328.2 (25), 327.1 (100, [M À Pr] ), 325.1 (26), 145.1 (14), 117.1 (16), 75.0 (12), 28.0
(34). HR-EI-MS: 327.1992 ([M À C3H7] , C17H31O4Si ; calc. 327.1991).
Dimethyl 3-{[(Isopropyloxy)dimethylsilyl]methyl}-4-methylcyclopentane-1,1-dicarboxylate (42). Prepared
according to GP 2 from 36 (212 mg, 1.0 mmol), 7 (425mg, 1.5mmol), and ( tBuO)2 (55 ml, 0.30 mmol) in hexane
(4 ml); 4 h, 1408. The solvent was removed in vacuo, the residue was dissolved in iPrOH (2 ml), and the resulting
soln. was treated with a cat. amount of NH4Cl and stirred overnight at r.t. The solvent was removed in vacuo, and
H2O and Et2O were added. The org. phase was separated, washed with brine, and dried (MgSO4). Purification
by FC (pentane/Et2O 40 :1) afforded 42 (175mg, 53%) as a colorless oil. Diastereoisomer ratio: cis/trans 15:10.
IR (nujol): 2956m, 2874w, 1736s, 1436w, 1381w, 1368w, 1253s, 1199m, 1172m, 1126m, 1027s, 882m, 840m.
1H-NMR (400 MHz, CDCl3): cis-42: 3.99 3.93 (m, Me2CH); 3.69 (s, 2 MeO); 2.41 2.34 (m, 2 H, CH, CH2);
2.15 2.04 ( m, 2 H, CH, CH2); 2.00 (dd, J1 13.6, J2 4.2, 1 H, CH2); 1.91 (dd, J1 13.3, J2 9.6, 1 H, CH2); 1.12
(d, J 6.1, Me2CH); 0.81 (d, J 6.6, Me); 0.64 (dd, J1 14.6, J2 4.7, 1 H, CH2Si); 0.51 (dd, J1 14.6, J2 9.2,
1
1 H, CH2Si); 0.10 (s, Me2Si). H-NMR (400 MHz, CDCl3): trans-42: 3.99 3.93 (m, Me2CH); 3.69 (s, 2 MeO);
2.59 (dd, J1 13.6, J2 6.7, 1 H, CH2); 2.48 (dd, J1 13.3, J2 6.4, 1 H, CH2); 1.73 1.64 (m, 2 H, CH, CH2);
1.38 1.15( m, 2 H, CH, CH2); 1.13 (d, J 6.0, Me2CH); 0.94 (d, J 5.9, Me); 0.90 0.82 (m, 1 H, CH2Si); 0.35
(dd, J1 15.6, J2 10.8, 1 H, CH2Si); 0.10 (s, Me2Si). 13C-NMR (100 MHz, CDCl3): cis-42: 173.40 (Cq); 64.77
(CH); 58.87 (Cq); 52.56 (Me); 43.38 (CH); 42.13 (CH2); 41.21 (CH2); 38.13 (CH); 25.78 (Me); 16.92 (CH2);
14.90 (Me); À0.57 (Me); À0.64 (Me). 13C-NMR (100 MHz, CDCl3): trans-42: 173.57 (Cq); 64.80 (CH); 58.13
(Cq); 52.56 (Me); 42.69 (CH); 42.69 (CH2); 40.55 (CH2); 37.57 (CH); 25.78 (Me); 20.38 (CH2); 17.14 (Me);
À0.81 (Me). EI-MS: 330 (2, M ), 315 (68), 271 (60), 270 (100), 257 (85), 197 (80), 189 (83), 154 (49), 145 (48),
140 (65), 123 (40), 117 (75), 108 (86), 107 (45), 95 (34), 91 (53), 81 (38), 75 (45), 45 (30). HR-EI-MS: 330.1856
(M , C16H30O5Si ; calc. 330.1863).
Dimethyl 3-(Hydroxymethyl)-4-methylcyclopentane-1,1-dicarboxylate (43). Ac2O (5.4 ml, 57 mmol) was
treated with 3 drops of conc. H2SO4 and cooled to 08. To this soln., H2O2 (3.60 ml, 35% in H2O, 42 mmol) was
added. The resulting soln. was stirred at r.t. for 30 min. Silane 38 (171 mg, 0.49 mmol) was dissolved in 6 ml of